The Investors for Opioid Accountability (IOA) was established in July 2007 out of heightened concerns that opioid company risks both threaten long-term shareholder value and have profound long-term implications for our economy and society.

The IOA uniquely represents influential and diverse funds from across the investing universe that are taking swift and decisive actions, using multiple shareholder resolutions, to hold manufacturers, distributors, and retail pharmacies company boards accountable for potential risks to shareholder value, the economy and society.

The IOA consists of 46 investors with over $2.2 trillion in assets under management and is co-led by Mercy Investment Services, Inc. and the UAW Retiree Medical Benefits Trust. The IOA’s diverse membership of faith-based, sustainability, public, and labor funds as well as Comptrollers, Treasurers and asset managers reflect the high level of concern investors have about board accountability and oversight of these opioid companies.

The IOA is calling on board of manufacturers, distributors and retail pharmacies to adopt or strengthen corporate governance practices that improve board independence, accountability and oversight related to opioid risks. Among the governance reforms the IOA is requesting is an independent board director investigation into on compliance, compensation, and board practices related to opioid risks as well as the adoption of a misconduct clawback provision, enhanced political lobbying and spending disclosures and the separation of chair and ceo positions.

Additional Information